ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $305,000 | -31.2% | 45,560 | +188.2% | 0.01% | -73.2% |
| Q1 2021 | $443,000 | -46.4% | 15,807 | -1.8% | 0.04% | -28.1% |
| Q2 2020 | $826,000 | -13.7% | 16,092 | -21.8% | 0.06% | -33.7% |
| Q2 2019 | $957,000 | +65.6% | 20,569 | +42.8% | 0.09% | +109.8% |
| Q1 2019 | $578,000 | +63.7% | 14,403 | +87.5% | 0.04% | +86.4% |
| Q4 2018 | $353,000 | -58.4% | 7,681 | -59.8% | 0.02% | -65.6% |
| Q3 2018 | $848,000 | +1.9% | 19,119 | +15.2% | 0.06% | -69.5% |
| Q3 2017 | $832,000 | +170.1% | 16,591 | -25.5% | 0.21% | +204.3% |
| Q3 2016 | $308,000 | -72.8% | 22,272 | -56.2% | 0.07% | -31.0% |
| Q4 2015 | $1,131,000 | -5.8% | 50,800 | -0.2% | 0.10% | -2.9% |
| Q3 2015 | $1,200,000 | – | 50,900 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |